← Evidence map

ArticleJournal of cancer research and clinical oncology2024

Can blood-based markers predict RECIST progression in non-small cell lung cancer treated with immunotherapy?

Melda Yeghaian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

6 papers cite it

2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 38922374